Go Pro
Patrick R. Trucchio

Patrick R. Trucchio Analyst Performance

Biotechnology Analyst at HC Wainwright

Patrick R. Trucchio is a stock analyst at HC Wainwright in the healthcare sector, covering 29 publicly traded companies. Over the past year, Patrick R. Trucchio has issued 104 stock ratings, including buy and hold recommendations. While full access to Patrick R. Trucchio's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Patrick R. Trucchio's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
104 Last 0 Years
Buy Recommendations
99.04% 103 Buy Ratings
Companies Covered
29 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy99.0%103 ratings
Hold1.0%1 ratings
Sell0.0%0 ratings

Out of 104 total stock ratings issued by Patrick R. Trucchio at HC Wainwright, the majority (99.0%) have been Buy recommendations, followed by 1.0% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
96.6% of companies on NASDAQ
28 companies
NYSE
3.4% of companies on NYSE
1 company

Patrick R. Trucchio, an analyst at HC Wainwright, currently covers 29 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
29 companies
100.0%

Patrick R. Trucchio of HC Wainwright specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
20 companies
69.0%
PHARMACEUTICALS
9 companies
31.0%

About Patrick R. Trucchio

Mr. Trucchio is a Managing Director of Equity Research at H.C. Wainwright whose research focuses on biotechnology, specifically on inflammation, fibrosis, cardio-metabolic, CNS, and rare diseases in addition to other areas. Mr. Trucchio has thirteen years of research experience on the sell-side. Prior to joining H.C. Wainwright, Mr. Trucchio was a senior equity research analyst at Berenberg Capital Markets (BCM) covering biotechnology and specialty pharmaceutical companies. Prior to Berenberg Capital Markets, Mr. Trucchio worked at Wells Fargo Securities and BMO Capital Markets. At Wells Fargo, Mr Trucchio worked on an Institutional Investor ranked analyst team covering specialty pharmaceutical companies. Mr. Trucchio’s educational background includes an M.B.A. with Honors from St. John’s University and a B.S. in Finance from The Pennsylvania State University.
Follow on LinkedIn

Patrick R. Trucchio's Ratings History at HC Wainwright

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
8/6/2026Boost Price Target$85.51$120.00Buy
Precision BioSciences, Inc. stock logo
DTIL
Precision BioSciences
8/3/2026Reiterated Rating$6.99Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
7/31/2026Lower Price Target$205.48$455.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
7/27/2026Boost Price Target$85.60$115.00Buy
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
7/27/2026Reiterated Rating$0.19Buy
Atai Beckley N.V. stock logo
ATAI
Atai Beckley
7/20/2026Downgrade$7.22$7.50Neutral
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
7/16/2026Reiterated Rating$33.18$55.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
7/13/2026Boost Price Target$288.04$485.00Buy
Precision BioSciences, Inc. stock logo
DTIL
Precision BioSciences
7/9/2026Reiterated Rating$9.28Buy
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
7/8/2026Reiterated Rating$13.17$70.00Buy
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
7/7/2026Reiterated Rating$35.32$80.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
7/1/2026Reiterated Rating$82.09$100.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
6/29/2026Lower Price Target$291.37$470.00Buy
uniQure N.V. stock logo
QURE
uniQure
6/29/2026Boost Price Target$47.51$80.00Buy
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
6/25/2026Lower Price Target$0.17$2.00Buy
Sensei Biotherapeutics, Inc. stock logo
FTH
Sensei Biotherapeutics
6/22/2026Initiated Coverage$17.82$60.00Buy
AgomAb Therapeutics NV stock logo
AGMB
AgomAb Therapeutics
6/22/2026Initiated Coverage$10.98$35.00Buy
Invivyd, Inc. stock logo
IVVD
Invivyd
6/15/2026Reiterated Rating$0.77$10.00Buy
Atai Beckley N.V. stock logo
ATAI
Atai Beckley
6/8/2026Reiterated Rating$3.95$25.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
6/4/2026Reiterated Rating$303.52$510.00Buy
Bright Minds Biosciences Inc. stock logo
DRUG
Bright Minds Biosciences
6/1/2026Reiterated Rating$84.06$145.00Buy
Precision BioSciences, Inc. stock logo
DTIL
Precision BioSciences
5/27/2026Reiterated Rating$7.76$60.00Buy
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
5/26/2026Reiterated Rating$0.21$5.00Buy
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
5/26/2026Reiterated Rating$0.81$10.00Buy
GH Research PLC stock logo
GHRS
GH Research
5/19/2026Lower Price Target$21.68$65.00Buy
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
5/11/2026Reiterated Rating$25.45$50.00Buy
uniQure N.V. stock logo
QURE
uniQure
5/6/2026Lower Price Target$21.61$50.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
5/5/2026Reiterated Rating$297.92$510.00Buy
Assembly Biosciences, Inc. stock logo
ASMB
Assembly Biosciences
5/4/2026Reiterated Rating$27.37$50.00Buy
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
4/28/2026Reiterated Rating$8.89$70.00Buy
NRx Pharmaceuticals, Inc. stock logo
NRXP
NRx Pharmaceuticals
4/27/2026Reiterated Rating$2.94$45.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
4/20/2026Reiterated Rating$31.41$100.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
4/14/2026Reiterated Rating$31.62$100.00Buy
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
4/2/2026Reiterated Rating$21.69$50.00Buy
Assembly Biosciences, Inc. stock logo
ASMB
Assembly Biosciences
3/26/2026Reiterated Rating$28.67$50.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
3/25/2026Reiterated Rating$325.35$510.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
3/25/2026Reiterated Rating$60.92$100.00Buy
Atai Beckley N.V. stock logo
ATAI
Atai Beckley
3/17/2026Reiterated Rating$3.68$25.00Buy
Voyager Therapeutics, Inc. stock logo
VYGR
Voyager Therapeutics
3/17/2026Reiterated Rating$3.96$25.00Buy
Altimmune, Inc. stock logo
ALT
Altimmune
3/16/2026Boost Price Target$3.60$25.00Buy
The $15 Gold Fund That Pays Up to $1,152/Month (Ad)

Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel

Discover the gold income fund before the next payout date
Silence Therapeutics PLC Sponsored ADR stock logo
SLN
Silence Therapeutics
3/13/2026Reiterated Rating$6.97$75.00Buy
Aligos Therapeutics, Inc. stock logo
ALGS
Aligos Therapeutics
3/11/2026Reiterated Rating$7.41$50.00Buy
uniQure N.V. stock logo
QURE
uniQure
3/10/2026Reiterated Rating$17.99$70.00Buy
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
3/6/2026Lower Price Target$0.52$5.00Buy
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
3/4/2026Boost Price Target$8.91$20.00Buy
Bright Minds Biosciences Inc. stock logo
DRUG
Bright Minds Biosciences
3/4/2026Boost Price Target$80.17$145.00Buy
NRx Pharmaceuticals, Inc. stock logo
NRXP
NRx Pharmaceuticals
3/3/2026Boost Price Target$1.84$45.00Buy
Pharvaris N.V. stock logo
PHVS
Pharvaris
3/3/2026Reiterated Rating$27.37$60.00Buy
GH Research PLC stock logo
GHRS
GH Research
3/2/2026Boost Price Target$14.85$70.00Buy
Atai Beckley N.V. stock logo
ATAI
Atai Beckley
3/2/2026Boost Price Target$3.63$25.00Buy
Compass Pathways PLC Sponsored ADR stock logo
CMPS
Compass Pathways
3/2/2026Boost Price Target$6.90$70.00Buy
Definium Therapeutics, Inc. stock logo
DFTX
Definium Therapeutics
3/2/2026Boost Price Target$17.45$70.00Buy
Cybin Inc. stock logo
HELP
Cybin
3/2/2026Boost Price Target$7.35$95.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
2/25/2026Reiterated Rating$28.34$55.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
2/18/2026Reiterated Rating$332.30$510.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
2/10/2026Reiterated Rating$62.56$100.00Buy
uniQure N.V. stock logo
QURE
uniQure
2/10/2026Reiterated Rating$26.05$70.00Buy
Sangamo Therapeutics, Inc. stock logo
SGMO
Sangamo Therapeutics
2/10/2026Reiterated Rating$0.40$10.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
2/4/2026Reiterated Rating$32.07$100.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
1/30/2026Lower Price Target$346.79$510.00Buy
Gossamer Bio, Inc. stock logo
GOSS
Gossamer Bio
1/22/2026Reiterated Rating$2.74$10.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
1/21/2026Boost Price Target$67.01$100.00Buy
Bright Minds Biosciences Inc. stock logo
DRUG
Bright Minds Biosciences
12/30/2025Reiterated Rating$79.38$115.00Buy
Assembly Biosciences, Inc. stock logo
ASMB
Assembly Biosciences
12/22/2025Reiterated Rating$36.19$50.00Buy
NRx Pharmaceuticals, Inc. stock logo
NRXP
NRx Pharmaceuticals
12/16/2025Reiterated Rating$1.98$40.00Buy
Marker Therapeutics, Inc. stock logo
MRKR
Marker Therapeutics
12/8/2025Initiated Coverage$1.32$10.00Buy
Pharvaris N.V. stock logo
PHVS
Pharvaris
12/3/2025Reiterated Rating$28.08$60.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
12/2/2025Boost Price Target$56.25$85.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
11/24/2025Reiterated Rating$34.78$55.00Buy
Oncolytics Biotech Inc. stock logo
ONCY
Oncolytics Biotech
11/17/2025Boost Price Target$1.04$10.00Buy
Pharvaris N.V. stock logo
PHVS
Pharvaris
11/13/2025Reiterated Rating$25.81$60.00Buy
Voyager Therapeutics, Inc. stock logo
VYGR
Voyager Therapeutics
11/12/2025Lower Price Target$4.23$25.00Buy
GH Research PLC stock logo
GHRS
GH Research
11/10/2025Lower Price Target$13.54$35.00Buy
Invivyd, Inc. stock logo
IVVD
Invivyd
10/31/2025Boost Price Target$1.81$10.00Buy
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
10/24/2025Boost Price Target$11.15$50.00Buy
Immunocore Holdings PLC Sponsored ADR stock logo
IMCR
Immunocore
10/22/2025Reiterated Rating$31.57$100.00Buy
Altimmune, Inc. stock logo
ALT
Altimmune
10/20/2025Reiterated Rating$3.83$12.00Buy
NRx Pharmaceuticals, Inc. stock logo
NRXP
NRx Pharmaceuticals
10/16/2025Reiterated Rating$3.17$40.00Buy
Pharvaris N.V. stock logo
PHVS
Pharvaris
10/15/2025Initiated Coverage$20.96$60.00Buy
Assembly Biosciences, Inc. stock logo
ASMB
Assembly Biosciences
10/14/2025Reiterated Rating$27.66$50.00Buy
Altimmune, Inc. stock logo
ALT
Altimmune
10/10/2025Reiterated Rating$4.00$12.00Buy
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
10/10/2025Reiterated Rating$27.87$80.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
10/10/2025Reiterated Rating$456.95$570.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
10/8/2025Reiterated Rating$36.54$80.00Buy
uniQure N.V. stock logo
QURE
uniQure
10/6/2025Boost Price Target$54.92$110.00Buy
NRx Pharmaceuticals, Inc. stock logo
NRXP
NRx Pharmaceuticals
10/1/2025Reiterated Rating$3.30$40.00Buy
Harmony Biosciences Holdings, Inc. stock logo
HRMY
Harmony Biosciences
9/25/2025Lower Price Target$26.76$55.00Buy
uniQure N.V. stock logo
QURE
uniQure
9/24/2025Reiterated Rating$39.80$70.00Buy
Atai Beckley N.V. stock logo
ATAI
Atai Beckley
9/23/2025Reiterated Rating$5.36$15.00Buy
Silence Therapeutics PLC Sponsored ADR stock logo
SLN
Silence Therapeutics
9/16/2025Reiterated Rating$4.73$75.00Buy
The Starlink of Energy (Ad)

A portable energy unit - already used by the U.S. Navy for decades - is now drawing serious attention from Big Tech and Washington policymakers. It can be trucked to a data center, military base, or industrial site and deliver reliable power for years without grid access. A key government milestone expected this August could bring significant visibility to this space. One small stock sits at the center of it.tc pixel

Read the full breakdown and see which stock to watch now
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
9/15/2025Reiterated Rating$20.60$80.00Buy
Voyager Therapeutics, Inc. stock logo
VYGR
Voyager Therapeutics
9/15/2025Reiterated Rating$4.18$30.00Buy
Bright Minds Biosciences Inc. stock logo
DRUG
Bright Minds Biosciences
9/15/2025Reiterated Rating$48.75$85.00Buy
Vir Biotechnology, Inc. stock logo
VIR
Vir Biotechnology
9/15/2025Reiterated Rating$4.80$15.00Buy
Aligos Therapeutics, Inc. stock logo
ALGS
Aligos Therapeutics
9/12/2025Reiterated Rating$10.31$50.00Buy
NRx Pharmaceuticals, Inc. stock logo
NRXP
NRx Pharmaceuticals
9/8/2025Initiated Coverage$2.75$40.00Buy
uniQure N.V. stock logo
QURE
uniQure
9/5/2025Reiterated Rating$17.56$70.00Buy
Sangamo Therapeutics, Inc. stock logo
SGMO
Sangamo Therapeutics
9/4/2025Reiterated Rating$0.53$10.00Buy
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
9/2/2025Reiterated Rating$446.87$570.00Buy
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
9/2/2025Reiterated Rating$24.88$80.00Buy
Invivyd, Inc. stock logo
IVVD
Invivyd
8/27/2025Reiterated Rating$1.03$5.00Buy
Bright Minds Biosciences Inc. stock logo
DRUG
Bright Minds Biosciences
8/19/2025Reiterated Rating$42.25$85.00Buy
Aligos Therapeutics, Inc. stock logo
ALGS
Aligos Therapeutics
8/18/2025Initiated Coverage$7.70$50.00Buy
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
8/18/2025Reiterated Rating$3.30$10.00Buy